No Data
Many heavyweight varieties lag behind peers, can OCUMENSION-B (01477) smoothly turn a profit?
At the time when the company is about to achieve breakeven, what is the actual value of Oukunwei Vision Bio, and is it worth entering the market early for layout?
OCUMENSION-B (01477) spent 1.551 million Hong Kong dollars to repurchase 0.323 million shares on April 16.
OCUMENSION-B (01477) announced that on April 16, 2025, it will spend 1.551 million Hong Kong dollars...
On April 11, OCUMENSION-B (01477.HK) spent 1.06 million HKD to repurchase 0.2255 million shares.
Gelonghui reported on April 11 that OCUMENSION-B (01477.HK) announced that it spent 1.06 million HKD to repurchase 0.2255 million shares on April 11.
On April 10, OCUMENSION-B (01477.HK) spent 4.75 million Hong Kong dollars to repurchase 1.026 million shares.
Gelonghui, April 10丨OCUMENSION-B (01477.HK) announced that on April 10, it spent 4.75 million Hong Kong dollars to repurchase 1.026 million shares.
On April 9, OCUMENSION-B (01477.HK) spent 0.687 million HKD to buy back 0.163 million shares.
Glory Exchange, April 9th: OCUMENSION-B (01477.HK) announced that on April 9th, it spent 0.687 million Hong Kong dollars to buy back 0.163 million shares.
On April 8, OCUMENSION-B (01477) spent HKD 0.1268 million to repurchase 0.0295 million shares.
OCUMENSION-B (01477) announced that it will invest 0.1268 million Hong Kong dollars on April 8, 2025 to repurchase...
Companies Like Ocumension Therapeutics (HKG:1477) Are In A Position To Invest In Growth
